Literature DB >> 28547654

Potential Teratogenic Effects of Clomiphene Citrate.

Alessandra Scaparrotta1, Francesco Chiarelli2, Alberto Verrotti3.   

Abstract

Clomiphene citrate (CC) is the oldest drug used to regulate the process of ovulation. Considering the great use of CC over the last 40 years, it is important to understand the possible risks associated with its use. The aim of this review was to evaluate the possible teratogenic effects of CC, analyzing results obtained from animal and human studies. The pharmacokinetics of CC and possible mechanisms involved in teratogenesis are examined. Fetal exposure to CC is possible due to the long half-life of CC and its metabolites. Alarming data have emerged from animal studies, although controversial results come from human studies. There is some evidence regarding a possible association of CC exposure and fetal malformations, mainly neural tube defects and hypospadias, which would require further investigation in order to allow safer use of this useful drug.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28547654     DOI: 10.1007/s40264-017-0546-x

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  46 in total

1.  Association of clomiphene with iniencephaly.

Authors:  Vikas Bhambhani; Sanila George
Journal:  Indian Pediatr       Date:  2004-05       Impact factor: 1.411

2.  Fetal safety of letrozole and clomiphene citrate for ovulation induction.

Authors:  Rachel Forman; Simmerpal Gill; Myla Moretti; Togas Tulandi; Gideon Koren; Robert Casper
Journal:  J Obstet Gynaecol Can       Date:  2007-08

3.  Oral administration of clomiphene to neonatal rats causes reproductive tract abnormalities.

Authors:  T Nagao; S Yoshimura
Journal:  Teratog Carcinog Mutagen       Date:  2001

Review 4.  Some iatrogenic ocular diseases from systemically administered drugs.

Authors:  H N Bernstein
Journal:  Int Ophthalmol Clin       Date:  1970

5.  Ovulation induction by clomiphene and neural tube defects.

Authors:  G M Shaw; E J Lammer; E M Velie
Journal:  Reprod Toxicol       Date:  1995 Jul-Aug       Impact factor: 3.143

6.  Acardius acephalus after induced ovulation: a case report.

Authors:  D A Haring; M C Cornel; J C van der Linden; J M van Vugt; M L Kwee
Journal:  Teratology       Date:  1993-04

7.  Histopathological changes in the uterus of rats treated neonatally with clomiphene citrate.

Authors:  E Deveci; A Onen; M Erdinç
Journal:  Clin Exp Obstet Gynecol       Date:  1997       Impact factor: 0.146

8.  Reproductive factors, subfertility, and risk of neural tube defects: a case-control study based on the Oxford Record Linkage Study Register.

Authors:  D Whiteman; M Murphy; K Hey; M O'Donnell; M Goldacre
Journal:  Am J Epidemiol       Date:  2000-11-01       Impact factor: 4.897

9.  Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization.

Authors:  P A Rogers; D Polson; C R Murphy; M Hosie; B Susil; M Leoni
Journal:  Fertil Steril       Date:  1991-03       Impact factor: 7.329

Review 10.  Clomiphene citrate and pregnancy outcome.

Authors:  A Venn; J Lumley
Journal:  Aust N Z J Obstet Gynaecol       Date:  1994-02       Impact factor: 2.100

View more
  2 in total

1.  Stem Cells as a Resource for Treatment of Infertility-related Diseases.

Authors:  Jing Wang; Chi Liu; Masayuki Fujino; Guoqing Tong; Qinxiu Zhang; Xiao-Kang Li; Hua Yan
Journal:  Curr Mol Med       Date:  2019       Impact factor: 2.222

2.  Reducing day 3 baseline monitoring bloodwork and ultrasound for patients undergoing timed intercourse and intrauterine insemination treatment cycles.

Authors:  Victoria O'Driscoll; Ilinca Georgescu; Irene Koo; Rebecca Arthur; Rita Chuang; Jillian Ann Dempsey; Giulia De Franco; Claire Ann Jones
Journal:  Fertil Res Pract       Date:  2021-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.